ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryLausanneFONDATION EUROVACC
FONDATION EUROVACC Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of EuroVacc is the development of safe and effective vaccines against HIV and other infectious diseases through the promotion and support of international collaborations with leading vaccine researchers and developers in the public and private sectors.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

FONDATION EUROVACC

✓ Offered6
Vaccine Research
Vaccine research against HIV and other infectious diseases, with translational development from discovery to early clinical development and collaboration with academic and industrial partners.
Support for Phase I/II Clinical Trials
Support and sponsorship of Phase I/II studies in Europe and Africa, including prophylactic and therapeutic HIV vaccine trials.
Scientific Project Management
Scientific project management for large research consortia, supporting development, manufacturing, regulatory work and clinical trials in infectious diseases.
International Research Collaborations
International collaborations with academic, public and private partners to advance vaccine candidates against HIV and other infectious diseases.
Scientific Publication of Results
Publication of scientific results on HIV vaccines and other infectious diseases in journals and conference contributions.
Research Funding Support
Securing and managing research grants and funding to support medical research against AIDS and other infectious diseases.
Trust & reputation

ranQ Trust Score of FONDATION EUROVACC: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

FONDATION EUROVACC has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
FONDATION EUROVACC scores 88.6 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
FONDATION EUROVACC scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
FONDATION EUROVACC scores 97.1 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.97.14%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

FONDATION EUROVACC reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once FONDATION EUROVACC has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

FONDATION EUROVACC in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank FONDATION EUROVACC by reviews, experience and specialisations.

Is this your company?

Claim the company profile of FONDATION EUROVACC to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Place Saint-François 1
1003 Lausanne

At a glance

Legal form
Foundation
UID
CHE-109.928.297
Founded
2002 · 24 years
Last commercial register change
March 10, 2025
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
97.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    IB
    Incyte Biosciences International Sàrl
    Morges
    AT
    ADC Therapeutics SA
    Epalinges
    BS
    Bial SA
    Nyon
    ES
    Exciva Switzerland SA
    Epalinges
    OB
    Opna Bio Switzerland Sàrl
    Epalinges
    FI
    fondation Innovative Medicines for Tuberculosis (iM4TB)
    Lausanne
    SB
    Swiss Biotech Laboratories Europe Sàrl
    Epalinges
    LH
    Legacy Healthcare (Switzerland) SA
    Epalinges